SummitTX Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Buy
288,889
+180,086
+166% +$1.38M 0.07% 291
2025
Q4
$1.06M Buy
+108,803
New +$925K 0.03% 408
2025
Q3
Sell
-69,202
Closed -$643K 944
2025
Q2
$643K Sell
69,202
-39,869
-37% -$348K 0.03% 461
2025
Q1
$1.06M Buy
+109,071
New +$1.35M 0.05% 392

Other funds holding REPL

SummitTX Capital's REPL Position: Q1 2026 in Review

SummitTX Capital increased its Replimune Group (REPL) stake by 166% in Q1 2026, buying an estimated $1.38M and bringing the position to 288,889 shares worth $2.21M. The position accounts for 0.07% of the portfolio, ranked #291.

SummitTX Capital first reported a position in REPL in Q1 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • SummitTX Capital held 288,889 shares of Replimune Group worth $2.21M as of Q1 2026.
  • SummitTX Capital bought 180,086 Replimune Group shares in Q1 2026, an estimated $1.38M.
  • Replimune Group made up 0.07% of SummitTX Capital's portfolio in Q1 2026, its #291 holding.
  • SummitTX Capital first reported a position in Replimune Group in Q1 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.